Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne VulgarisANTIBIOTICS-BASELIF4.62020-01-1331OAAI
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis TreatmentANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-11-0120OAAI
Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and BiofilmFRONTIERS IN MICROBIOLOGYIF4.52019-07-2443OAAI
Designed Host Defense Peptides for the Treatment of Bacterial KeratitisINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72017-12-1437OAAI
Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in ratsPHARMACOLOGICAL RESEARCHIF10.52016-11-0122PREAI
pMNTC Is a Cone-Specific Regulatory Cassette Designed To Treat Cone-Associated DisordersMOLECULAR THERAPYIF122015-05-010OAAI
Genotoxic assessment and toxicity evaluation of peginesatide in CByB6F1 hybrid miceDRUG AND CHEMICAL TOXICOLOGYIF1.92011-06-075PREAI
ERYTHROPOIESIS EQUIVALENCE, PHARMACOKINETICS AND IMMUNE RESPONSE FOLLOWING REPEAT HEMATIDE™ ADMINISTRATION IN CYNOMOLGUS MONKEYSINTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGYIF2.62010-01-0111OAAI
Pharmacokinetics (PK), safety, and pharmacodynamics (PD) of Hematide™ a synthetic peptide-based erythropoiesis stimulating agent (ESA), in a phase 1 single dose, dose escalating study in normal healthy volunteers (NHVS).CLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52006-02-010OAAI
Post surgical pain management with poly(ortho esters)ADVANCED DRUG DELIVERY REVIEWSIF17.62002-10-0125PREAI
Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery diseaseTRANSPLANTATIONIF52001-06-0125OA
Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cellsARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42001-05-0144PREAI
Lutetium texaphyrin (lu-tex): A potential new agent for ocular fundus angiography and photodynamic therapyAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22000-03-0155PREAI
In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.51999-11-01104PREAI
Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrinJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.71998-05-0195OAAI
Evaluation of texaphyrins as tumor selective radiation sensitizersINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.51997-01-011PREAI
BIODISTRIBUTION OF HEMATOPORPHYRIN ANALOGS IN A LUNG-CARCINOMA MODELCANCER LETTERSIF10.11995-01-0140PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向